My 35-year-old husband has young-onset Parkinson’s disease (YOPD). It sucks. I’m often asked, “How’s Todd?” or “How’s your husband’s health?” or “Is Todd staying healthy?” Thank you for asking about my husband. I’m happy to say he’s doing pretty darn good, considering he has a progressive neurological disease and we don’t know what the future holds. No, he does not have dementia, a question I was asked last week.
National Parkinson Foundation's blog
A French group presented data at the 20th International Congress of Parkinson’s Disease and Movement Disorders in Berlin Germany last month. Their results suggested a strong link between farming, pesticides and risk of Parkinson’s disease. Sofiane Kab and her colleagues demonstrated that living in rural French regions with more crops was a high risk for the later developing Parkinson’s. The authors noted that these are typically regions where vineyards are located.
Every year, the Parkinson's Foundation hosts the Centers of Excellence Leadership Conference, where leaders from our 42 Centers of Excellence — medical centers located around the world with leading Parkinson's specialists — attend and present their cutting-edge research and expert care findings. Dr.
We are blessed to have the terrific and free Parkinson's Foundation 1-800-4PD-INFO Helpline staffed by nurses and social workers with experience in the field. Recently, many people have called the Helpline after seeing a video declaring focused ultrasound therapy as “the scalpel-less cure for Parkinson’s disease.” The Helpline staff thought it important to objectively explore this therapy and discuss whether it is indeed a scalpel-less cure.
This blog is the second in a series detailing the roles of each member of a comprehensive care team.
I arrived at my Parkinson’s Caregivers Support Group a little late. Getting out of the house with Gerry, my husband, had taken a bit longer than our new normal. And, of course, when I tried to hurry so that I could be on time, it took even longer.
In January 2012 we reported on the possibility of a blood test for Parkinson’s disease detection. Four years have now passed, and this week a different group from La Trobe University led by Paul Fisher say they have developed and potentially effective blood test for Parkinson’s disease detection. In this month’s What’s Hot in PD? Column, we will update our previous article and comment on this new observation.
Every year, the Parkinson's Foundation hosts the Centers of Excellence Leadership Conference, where leaders from our 42 Centers of Excellence — medical centers located around the world with the world's leading Parkinson's specialists — attend and present their cutting-edge research and expert care findings.
This week the FDA approved the drug Pimavanserin (Nuplazid) for the treatment of Parkinson’s disease psychosis. There has been a critical, unmet need for development of better drugs to address hallucinations and psychosis in the setting of Parkinson's disease. We have learned over many years that typical high potency neuroleptic antipsychotic drugs (e.g.
Yoga can benefit both persons with PD and their care partners, but often people don’t know how to get started. This is part one; tune in next month for part two!